Acutaas Chemicals Ltd
NSE:ACUTAAS

Watchlist Manager
Acutaas Chemicals Ltd Logo
Acutaas Chemicals Ltd
NSE:ACUTAAS
Watchlist
Price: 1 681.9 INR 0.94% Market Closed
Market Cap: 137.7B INR

Acutaas Chemicals Ltd
EPS (Diluted)

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
TTM
|
See Also

Acutaas Chemicals Ltd
EPS (Diluted) Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company EPS (Diluted) CAGR 3Y CAGR 5Y CAGR 10Y
Acutaas Chemicals Ltd
NSE:ACUTAAS
EPS (Diluted)
₹19
CAGR 3-Years
24%
CAGR 5-Years
39%
CAGR 10-Years
N/A
Dr Reddy's Laboratories Ltd
NSE:DRREDDY
EPS (Diluted)
₹69
CAGR 3-Years
-28%
CAGR 5-Years
-6%
CAGR 10-Years
-2%
Cipla Ltd
NSE:CIPLA
EPS (Diluted)
₹67
CAGR 3-Years
28%
CAGR 5-Years
24%
CAGR 10-Years
12%
Sun Pharmaceutical Industries Ltd
NSE:SUNPHARMA
EPS (Diluted)
₹43
CAGR 3-Years
37%
CAGR 5-Years
48%
CAGR 10-Years
14%
Lupin Ltd
NSE:LUPIN
EPS (Diluted)
₹94
CAGR 3-Years
299%
CAGR 5-Years
N/A
CAGR 10-Years
7%
T
Torrent Pharmaceuticals Ltd
NSE:TORNTPHARM
EPS (Diluted)
₹63
CAGR 3-Years
39%
CAGR 5-Years
12%
CAGR 10-Years
4%
No Stocks Found

Acutaas Chemicals Ltd
Glance View

Market Cap
137.7B INR
Industry
Pharmaceuticals

Acutaas Chemicals Ltd. engages in the development and commercialization of pharmaceutical intermediate products and specialty chemicals. The company is headquartered in Surat, Gujarat. The company went IPO on 2021-09-14. The company is focused on the development and manufacturing of advanced pharmaceutical intermediates (Pharma Intermediates), New Chemical Entities (NCE) and other specialty chemicals for pharmaceuticals, agrochemicals, dyes, polymers, personal care, animal food, and other industries. The company manufactures pharma intermediates for certain active pharmaceutical ingredients (APIs), including dolutegravir, trazodone, entacapone, nintedanib, and rivaroxaban. The pharma intermediates cater to several therapeutic areas, including anti-retroviral, anti-inflammatory, anti-psychotic, anti-cancer, anti-Parkinson, anti-depressant, and anti-coagulant. The company has developed and commercialized over 520 plus products, including specialty chemicals, Pharma Intermediates for APIs across 23 key therapeutic areas since inception and NCE across select high-growth high margin chronic therapeutic areas.

ACUTAAS Intrinsic Value
1 188.16 INR
Overvaluation 29%
Intrinsic Value
Price

See Also

What is Acutaas Chemicals Ltd's EPS (Diluted)?
EPS (Diluted)
19.8 INR

Based on the financial report for Mar 31, 2025, Acutaas Chemicals Ltd's EPS (Diluted) amounts to 19.8 INR.

What is Acutaas Chemicals Ltd's EPS (Diluted) growth rate?
EPS (Diluted) CAGR 5Y
39%

Over the last year, the EPS (Diluted) growth was 240%. The average annual EPS (Diluted) growth rates for Acutaas Chemicals Ltd have been 24% over the past three years , 39% over the past five years .

Back to Top